NetworkNewsBreaks – Nutriband Inc. (NASDAQ: NTRB
Post# of 51

Nutriband (NASDAQ: NTRB) announced that its Board of Directors has approved a 25% preferred stock dividend, granting one preferred share for every four common shares held as of July 25, 2025, with distribution set for August 5. Each preferred share will convert to one common share upon FDA approval of the Company’s AVERSA Fentanyl product. If not converted, preferred shares will be eligible for annual cash dividends from company profits at the Board’s discretion. CEO Gareth Sheridan said the move reflects the Company’s commitment to shareholder value as it advances toward AVERSA commercialization.
NOTE TO INVESTORS: The latest news and updates relating to NTRB are available in the company’s newsroom at https://nnw.fm/NTRB
Please see full terms of use and disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or republished: http://NNW.fm/Disclaimer

